Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- English Abstract1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Fortschr Med1
Search Results
Sort by
- ArticleRiedel H, Burkert W.Fortschr Med. 1978 Sep 28;96(36):1800-3.Thrombelastography, as a method of rapid registration, is an important addition to the present screening tests of coagulation status. With this method we are able to quickly obtain exact values for clotting and fibrinolysis with more precision than those which can be obtained from the clot observation test. The TEG monitor must however be available in the immediate vicinity of the labour ward and must be ready for use around the clock. Specific therapy for the elimination of failures in hemostasis may then be started without delay, due to prompt determination of coagulation status and early detection of fibrinolysis.
- Bookeditors, Arun Rajan, Giuseppe Giaccone.Contents:
Targeted therapy for non-small-cell lung cancer / Arun Rajan & Giuseppe Giaccone
Overview of pathophysiology and drug targets for non-small-cell lung cancer / Anish Thomas, Arun Rajan & Giuseppe Giaccone
EGFR inhibitors and their use in the treatment of metastatic disease / Cesare Gridelli & Antonio Rossi
VEGF receptor inhibitors / Ariel Lopez-Chavez & Alan Sandler
CTLA-4 inhibitor : ipilimumab for the treatment of NSCLC / Julie R. Brahmer
VEGF receptor inhibitors / Kavitha Ramchandran, Millie Das & Heather Wakelee
HGFR/MET and ALK inhibitors / Eunice L. Kwak
Vaccines for lung cancer / Ronan J. Kelly
Index.